Moderna to Host R&D Day on Thursday, September 8, 2022

Rhea-AI Summary

Moderna (Nasdaq:MRNA) will host its R&D Day on September 8, 2022, at 9:00 a.m. ET, available both in-person and virtually. The event will feature key presentations from CEO Stéphane Bancel and President Stephen Hoge, M.D., along with the Moderna clinical team. Interested parties can access a live webcast through the Investors section of Moderna's website, with a replay available for one year post-event. Moderna, a leader in mRNA therapeutics, has a diverse clinical portfolio and significant collaborations impacting vaccine development.

CAMBRIDGE, MA / ACCESSWIRE / August 29, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it will host its in-person and virtual R&D Day at 9:00 a.m. ET on Thursday, September 8, 2022.

Moderna's R&D Day will feature presentations from Stéphane Bancel, Chief Executive Officer, Stephen Hoge M.D., President, and Moderna clinical team leaders.

A live webcast will be available under "Events and Presentations" in the Investors section of the Moderna website. A replay of the webcast will be archived on Moderna's website for one year following the presentation.

About Moderna

In over 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for rapid clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use and approval of one of the earliest and most effective vaccines against the COVID-19 pandemic.

Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit www.modernatx.com.

Moderna Contact
Lavina Talukdar
Senior Vice President& Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View source version on accesswire.com:
https://www.accesswire.com/712213/Moderna-to-Host-RD-Day-on-Thursday-September-8-2022

FAQ

When is Moderna's R&D Day scheduled for 2022?

Moderna's R&D Day is scheduled for September 8, 2022, at 9:00 a.m. ET.

How can I watch Moderna's R&D Day presentations?

You can watch Moderna's R&D Day presentations via a live webcast available in the Investors section of their website.

Who will speak at Moderna's R&D Day?

Stéphane Bancel, CEO, and Stephen Hoge, M.D., President, along with Moderna's clinical team leaders will present.

What is Moderna known for in the biotechnology field?

Moderna is known for pioneering messenger RNA (mRNA) therapeutics and vaccines, including its COVID-19 vaccine.

How long will the webcast of Moderna's R&D Day be available?

The webcast of Moderna's R&D Day will be archived on their website for one year following the event.